Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-ROR1 antibody and ROR1-targeting engineered cells

Anti-ROR1 antibody and ROR1-targeting engineered cells

US Patent 12492264 · Granted Dec 9, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CS1 antibody and anti-CS1-CAR-t cells2025
CS1 antibody and anti-CS1-CAR-t cells2025
Humanized BCMA antibody and BCMA-CAR-T cells2025
Humanized BCMA antibody and BCMA-CAR-T cells2025
Epcam antibody and Epcam-CAR-T cells2025
CAR-T cells with humanized CD19 ScFv with mutation in CDR 1 region2025
Humanized BCMA antibody and BCMA-CAR-T cells2024
CAR-T cells with humanized CD19 ScFv2024
BCMA-CAR-T cells2024
PLAP-CAR-effector cells2024
Anti-ROR1 antibody and ROR1-targeting engineered cells2024
Chimeric antigen receptors comprising a human transferrin epitope sequence2023